SILEXION THERAPEUTICS CORP (SLXNW) Free cash flow 2023–2025
SILEXION THERAPEUTICS CORP (SLXNW) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$10.8MFY2025 · since FY2023: -$4.5M → -$10.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$10.8M | -28.6% |
| FY2024 | -$8.4M | -85.4% |
| FY2023 | -$4.5M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice